Squarepoint’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.85M | Buy |
+273,330
| New | +$9.85M | 0.01% | 567 |
|
|
2025
Q1 | – | Sell |
-384,132
| Closed | -$9.8M | – | 3148 |
|
|
2024
Q4 | $9.8M | Sell |
384,132
-234,551
| -38% | -$5.98M | 0.01% | 551 |
|
|
2024
Q3 | $17.5M | Buy |
618,683
+217,157
| +54% | +$6.14M | 0.03% | 330 |
|
|
2024
Q2 | $10.6M | Sell |
401,526
-222,513
| -36% | -$5.87M | 0.02% | 452 |
|
|
2024
Q1 | $19M | Sell |
624,039
-276,855
| -31% | -$8.41M | 0.03% | 307 |
|
|
2023
Q4 | $25.3M | Sell |
900,894
-55,662
| -6% | -$1.56M | 0.05% | 217 |
|
|
2023
Q3 | $26M | Buy |
956,556
+521,226
| +120% | +$14.1M | 0.06% | 194 |
|
|
2023
Q2 | $13.4M | Sell |
435,330
-79,379
| -15% | -$2.44M | 0.04% | 302 |
|
|
2023
Q1 | $18.5M | Buy |
514,709
+227,440
| +79% | +$8.19M | 0.08% | 192 |
|
|
2022
Q4 | $11.4M | Buy |
287,269
+195,214
| +212% | +$7.71M | 0.04% | 270 |
|
|
2022
Q3 | $3.7M | Sell |
92,055
-85,185
| -48% | -$3.42M | 0.02% | 557 |
|
|
2022
Q2 | $7.45M | Sell |
177,240
-3,413
| -2% | -$143K | 0.04% | 330 |
|
|
2022
Q1 | $7.04M | Sell |
180,653
-188,375
| -51% | -$7.34M | 0.03% | 387 |
|
|
2021
Q4 | $14.7M | Buy |
369,028
+132,435
| +56% | +$5.28M | 0.04% | 250 |
|
|
2021
Q3 | $8.55M | Buy |
236,593
+60,441
| +34% | +$2.18M | 0.02% | 330 |
|
|
2021
Q2 | $7.22M | Buy |
176,152
+161,570
| +1,108% | +$6.62M | 0.03% | 369 |
|
|
2021
Q1 | $636K | Sell |
14,582
-6,611
| -31% | -$288K | ﹤0.01% | 1371 |
|
|
2020
Q4 | $1.06M | Buy |
+21,193
| New | +$1.06M | 0.01% | 1045 |
|
|
2020
Q3 | – | Sell |
-200,000
| Closed | -$9.71M | – | 2630 |
|
|
2020
Q2 | $9.71M | Buy |
+200,000
| New | +$9.71M | 0.16% | 172 |
|